drug
ranolazine ER
Marketedupdated 5mo agoby Laurus Generics Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying ranolazine ER
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 24, 2038
~11.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jan 24, 2038formulationUS 10898444
- Jan 24, 2038formulationUS 11510878
- Jan 24, 2038formulationUS 11510878
- Jan 24, 2038formulationUS 12161761
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that